X-71118727-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6_ModerateBS1BS2

The NM_005120.3(MED12):​c.-28G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000925 in 1,188,876 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 39 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.000055 ( 0 hom., 3 hem., cov: 20)
Exomes 𝑓: 0.000096 ( 0 hom. 36 hem. )

Consequence

MED12
NM_005120.3 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 1.50

Publications

0 publications found
Variant links:
Genes affected
MED12 (HGNC:11957): (mediator complex subunit 12) The initiation of transcription is controlled in part by a large protein assembly known as the preinitiation complex. A component of this preinitiation complex is a 1.2 MDa protein aggregate called Mediator. This Mediator component binds with a CDK8 subcomplex which contains the protein encoded by this gene, mediator complex subunit 12 (MED12), along with MED13, CDK8 kinase, and cyclin C. The CDK8 subcomplex modulates Mediator-polymerase II interactions and thereby regulates transcription initiation and reinitation rates. The MED12 protein is essential for activating CDK8 kinase. Defects in this gene cause X-linked Opitz-Kaveggia syndrome, also known as FG syndrome, and Lujan-Fryns syndrome. [provided by RefSeq, Aug 2009]
MED12 Gene-Disease associations (from GenCC):
  • FG syndrome 1
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • MED12-related intellectual disability syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked intellectual disability with marfanoid habitus
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • blepharophimosis - intellectual disability syndrome, MKB type
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • cholestasis-pigmentary retinopathy-cleft palate syndrome
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant X-71118727-G-T is Benign according to our data. Variant chrX-71118727-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 507960.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0000545 (6/110088) while in subpopulation NFE AF = 0.000095 (5/52632). AF 95% confidence interval is 0.0000372. There are 0 homozygotes in GnomAd4. There are 3 alleles in the male GnomAd4 subpopulation. Median coverage is 20. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 3 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MED12NM_005120.3 linkc.-28G>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 45 ENST00000374080.8 NP_005111.2 Q93074-1
MED12NM_005120.3 linkc.-28G>T 5_prime_UTR_variant Exon 1 of 45 ENST00000374080.8 NP_005111.2 Q93074-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MED12ENST00000374080.8 linkc.-28G>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 45 1 NM_005120.3 ENSP00000363193.3 Q93074-1
MED12ENST00000374080.8 linkc.-28G>T 5_prime_UTR_variant Exon 1 of 45 1 NM_005120.3 ENSP00000363193.3 Q93074-1

Frequencies

GnomAD3 genomes
AF:
0.0000545
AC:
6
AN:
110088
Hom.:
0
Cov.:
20
show subpopulations
Gnomad AFR
AF:
0.0000331
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000950
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000462
AC:
7
AN:
151614
AF XY:
0.0000830
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000109
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000964
AC:
104
AN:
1078788
Hom.:
0
Cov.:
29
AF XY:
0.000103
AC XY:
36
AN XY:
348328
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25890
American (AMR)
AF:
0.00
AC:
0
AN:
34002
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19133
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29420
South Asian (SAS)
AF:
0.00
AC:
0
AN:
52286
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39447
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3872
European-Non Finnish (NFE)
AF:
0.000125
AC:
104
AN:
829412
Other (OTH)
AF:
0.00
AC:
0
AN:
45326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.524
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000545
AC:
6
AN:
110088
Hom.:
0
Cov.:
20
AF XY:
0.0000928
AC XY:
3
AN XY:
32326
show subpopulations
African (AFR)
AF:
0.0000331
AC:
1
AN:
30207
American (AMR)
AF:
0.00
AC:
0
AN:
10366
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2622
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3501
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2542
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5833
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.0000950
AC:
5
AN:
52632
Other (OTH)
AF:
0.00
AC:
0
AN:
1473
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.542
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000756

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 17, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.35
CADD
Benign
19
DANN
Benign
0.88
PhyloP100
1.5
PromoterAI
0.028
Neutral
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs373552360; hg19: chrX-70338577; COSMIC: COSV61334876; API